Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-01
DOI
10.1038/s41698-020-00129-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models
- (2020) Regina Padmanabhan et al. Cancers
- PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers
- (2019) Yanjun Hou et al. HUMAN PATHOLOGY
- Bee Venom and Its Peptide Component Melittin Suppress Growth and Migration of Melanoma Cells via Inhibition of PI3K/AKT/mTOR and MAPK Pathways
- (2019) Haet Lim et al. MOLECULES
- Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
- (2019) Anabel Sorolla et al. Nanomedicine-Nanotechnology Biology and Medicine
- Synergistic Effects of Melittin and Plasma Treatment: A Promising Approach for Cancer Therapy
- (2019) Priyanka Shaw et al. Cancers
- Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion
- (2018) Bharat K.R. Chaganty et al. CANCER LETTERS
- Checkpoint inhibitors in breast cancer – Current status
- (2018) Anne Polk et al. CANCER TREATMENT REVIEWS
- ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
- (2018) James Monypenny et al. Cell Reports
- Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
- (2018) Samantha I. Liang et al. Cell Reports
- Melittin induces NSCLC apoptosis via inhibition of miR-183
- (2018) Dongqi Gao et al. OncoTargets and Therapy
- Anti-cancer effect of bee venom on human MDA-MB-231 breast cancer cells using Raman spectroscopy
- (2018) Gyeong Bok Jung et al. Biomedical Optics Express
- Apoptotic Effect of Melittin Purified from Iranian Honey Bee Venom on Human Cervical Cancer HeLa Cell Line
- (2017) Hannaneh Zarrinnahad et al. International Journal of Peptide Research and Therapeutics
- Molecular cloning of the Bombus terrestris bumblebee venom protein phospholipase A 2 and its anti-leukemia effects on K562 cells
- (2017) Yuling Qiu et al. JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells
- (2017) Mohsen Sisakht et al. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
- Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model
- (2017) Chanju Lee et al. Oncotarget
- Molecular cloning of the Bombus terrestris bumblebee venom protein phospholipase A 2 and its anti-leukemia effects on K562 cells
- (2017) Yuling Qiu et al. JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
- Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells
- (2017) Mohsen Sisakht et al. Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
- Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden—Reply
- (2017) Christina Fitzmaurice et al. JAMA Oncology
- The Interaction of Melittin with Dimyristoyl Phosphatidylcholine-Dimyristoyl Phosphatidylserine Lipid Bilayer Membranes
- (2016) Durgesh K. Rai et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer
- (2016) WENTONG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide
- (2016) A. Sorolla et al. Nanoscale
- Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
- (2016) Debora de Melo Gagliato et al. Oncotarget
- NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions
- (2015) Thomas Machleidt et al. ACS Chemical Biology
- Molecular Dynamics Study of Pore Formation by Melittin in a 1,2-Dioleoyl-sn-glycero-3-phosphocholine and 1,2-Di(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) Mixed Lipid Bilayer
- (2015) Yuan Lyu et al. INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
- Conformational Fine-Tuning of Pore-Forming Peptide Potency and Selectivity
- (2015) Aram J. Krauson et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Multistep Molecular Dynamics Simulations Identify the Highly Cooperative Activity of Melittin in Recognizing and Stabilizing Membrane Pores
- (2015) Delin Sun et al. LANGMUIR
- Application of BRET to monitor ligand binding to GPCRs
- (2015) Leigh A Stoddart et al. NATURE METHODS
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unraveling the venom proteome of the bumblebee (Bombus terrestris) by integrating a combinatorial peptide ligand library approach with FT-ICR MS
- (2015) Matthias Van Vaerenbergh et al. TOXICON
- High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer
- (2015) Tao Qin et al. Oncotarget
- The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM
- (2015) Dejun Sun et al. Toxins
- Dual secured nano-melittin for the safe and effective eradication of cancer cells
- (2015) Bei Cheng et al. Journal of Materials Chemistry B
- Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
- (2014) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure
- (2014) Masayuki Kohno et al. CHEMISTRY & BIOLOGY
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells
- (2014) Yun-Jeong Jeong et al. FOOD AND CHEMICAL TOXICOLOGY
- Structural determinants of integrin β-subunit specificity for latent TGF-β
- (2014) Xianchi Dong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cancer Cell Growth Inhibitory Effect of Bee Venom via Increase of Death Receptor 3 Expression and Inactivation of NF-kappa B in NSCLC Cells
- (2014) Kyung Choi et al. Toxins
- Combined antitumor effects of bee venom and cisplatin on human cervical and laryngeal carcinoma cells and their drug resistant sublines
- (2013) Goran Gajski et al. JOURNAL OF APPLIED TOXICOLOGY
- Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function
- (2013) A S Beltran et al. ONCOGENE
- Process of inducing pores in membranes by melittin
- (2013) M.-T. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
- (2012) Mary P. Hall et al. ACS Chemical Biology
- Targeting triple-negative breast cancer: optimising therapeutic outcomes
- (2012) K. Gelmon et al. ANNALS OF ONCOLOGY
- Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
- (2012) P. J. Roberts et al. CLINICAL CANCER RESEARCH
- The dynamics of melittin-induced membrane permeability
- (2012) Gašper Kokot et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway
- (2011) Miran Jo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The role of electrostatic interactions in the membrane binding of melittin
- (2010) Kristopher Hall et al. JOURNAL OF MOLECULAR RECOGNITION
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
- (2009) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level
- (2009) Enrique Barrajón-Catalán et al. CANCER LETTERS
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- Cell-penetrating peptides: from molecular mechanisms to therapeutics
- (2008) May C. Morris et al. BIOLOGY OF THE CELL
- Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR β signalling
- (2008) Marion T. Weigel et al. CANCER LETTERS
- Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells
- (2008) Wu-Chun Tu et al. TOXICON
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started